"Tuberculosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS.
Descriptor ID |
D014376
|
MeSH Number(s) |
C01.252.410.040.552.846
|
Concept/Terms |
Tuberculosis- Tuberculosis
- Tuberculoses
- Koch's Disease
- Koch Disease
- Kochs Disease
- Mycobacterium tuberculosis Infection
- Infection, Mycobacterium tuberculosis
- Infections, Mycobacterium tuberculosis
- Mycobacterium tuberculosis Infections
|
Below are MeSH descriptors whose meaning is more general than "Tuberculosis".
Below are MeSH descriptors whose meaning is more specific than "Tuberculosis".
- Tuberculosis
- Latent Tuberculosis
- Peritonitis, Tuberculous
- Tuberculoma
- Tuberculosis, Avian
- Tuberculosis, Bovine
- Tuberculosis, Cardiovascular
- Tuberculosis, Central Nervous System
- Tuberculosis, Cutaneous
- Tuberculosis, Endocrine
- Tuberculosis, Gastrointestinal
- Tuberculosis, Hepatic
- Tuberculosis, Laryngeal
- Tuberculosis, Lymph Node
- Tuberculosis, Miliary
- Tuberculosis, Multidrug-Resistant
- Tuberculosis, Ocular
- Tuberculosis, Oral
- Tuberculosis, Osteoarticular
- Tuberculosis, Pleural
- Tuberculosis, Pulmonary
- Tuberculosis, Splenic
- Tuberculosis, Urogenital
This graph shows the total number of publications written about "Tuberculosis" by people in this website by year, and whether "Tuberculosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 0 | 2 |
1995 | 4 | 0 | 4 |
1996 | 1 | 0 | 1 |
1997 | 2 | 1 | 3 |
1998 | 1 | 2 | 3 |
1999 | 4 | 1 | 5 |
2000 | 6 | 0 | 6 |
2001 | 3 | 1 | 4 |
2002 | 5 | 2 | 7 |
2003 | 2 | 0 | 2 |
2004 | 4 | 1 | 5 |
2005 | 6 | 3 | 9 |
2006 | 6 | 1 | 7 |
2007 | 5 | 1 | 6 |
2008 | 8 | 2 | 10 |
2009 | 4 | 1 | 5 |
2010 | 10 | 2 | 12 |
2011 | 15 | 1 | 16 |
2012 | 13 | 1 | 14 |
2013 | 14 | 1 | 15 |
2014 | 18 | 1 | 19 |
2015 | 12 | 2 | 14 |
2016 | 21 | 0 | 21 |
2017 | 19 | 1 | 20 |
2018 | 19 | 2 | 21 |
2019 | 30 | 1 | 31 |
2020 | 18 | 1 | 19 |
2021 | 13 | 2 | 15 |
2022 | 22 | 0 | 22 |
2023 | 19 | 0 | 19 |
2024 | 7 | 0 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tuberculosis" by people in Profiles.
-
Integration of HIV Testing in a Community Intervention for Tuberculosis Screening Among Household Contacts of Patients with Tuberculosis in Cameroon and Uganda. J Acquir Immune Defic Syndr. 2024 Apr 15; 95(5):431-438.
-
Tuberculosis in people of Ukrainian origin in the European Union and the European Economic Area, 2019 to 2022. Euro Surveill. 2024 Mar; 29(12).
-
A stool based qPCR for the diagnosis of TB in children and people living with HIV in Uganda, Eswatini and Mozambique (Stool4TB): a protocol for a multicenter diagnostic evaluation. BMC Infect Dis. 2024 Feb 21; 24(1):233.
-
Activin A levels are raised during human tuberculosis and blockade of the activin signaling axis influences murine responses to M. tuberculosis infection. mBio. 2024 Mar 13; 15(3):e0340823.
-
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial. Nat Med. 2024 Mar; 30(3):896-904.
-
Immune mapping of human tuberculosis and sarcoidosis lung granulomas. Front Immunol. 2023; 14:1332733.
-
Chronic Pulmonary Aspergillosis as a Considerable Complication in Post-Tuberculosis Lung Disease. Semin Respir Crit Care Med. 2024 Feb; 45(1):102-113.
-
Sustained high fatality during TB therapy amid rapid decline in TB mortality at population level: A retrospective cohort and ecological analysis from Shiselweni, Eswatini. Trop Med Int Health. 2024 03; 29(3):192-205.
-
Anti-Tuberculosis Potential of OJT008 against Active and Multi-Drug-Resistant Mycobacterium Tuberculosis: In Silico and In Vitro Inhibition of Methionine Aminopeptidase. Int J Mol Sci. 2023 Dec 05; 24(24).
-
[Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP)]. Pneumologie. 2024 Jan; 78(1):35-46.